Small Interfering RNA (siRNA) Therapeutics Market Size, Share & Trends Analysis Report By Delivery (Lipid Nanoparticles (LNPs), Conjugates), by Indication (Hereditary Transthyretin-mediated Amyloidosis, Acute Hepatic Porphyria, Primary Hyperoxaluria Type 1, Primary Hypercholesterolemia, Others), by RoA (Intravenous (IV), Subcutaneous), By Region, And By Segment Forecasts, 2024-2031
The Small Interfering RNA (siRNA) Therapeutics Market Size is valued at USD 1.6 Bn in 2023 and is predicted to reach USD 4.89 Bn by the year 2031 at a 15.0% CAGR during the forecast period for 2024-2031. Small interfering RNA (siRNA) therapeutics describe a group of medicinal interventions that target disease-causing genes using small, engineered RNA molecules. Market expansion for siRNA treatments is driven by rising demand for pre...
Report ID: 2629 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 178
mRNA Treatment Market Size, Share and Trends Analysis 2025 to 2034
Global mRNA Treatment Market Size is estimated to be valued at 8.03 billion in 2024 and is predicted to reach 1.05 billion by the year 2031 at a 9.0% CAGR during 2028 to 2034. mRNA Treatment Market Size, Share & Trends Analysis Report By Product Type (Prophylactic vaccines, Therapeutic vaccines, Therapeutic drugs), By Therapeutic Area, By Route of Administration, By Region, And Segment Forecasts, 2025 to 2034 Key Industry Insights & F...
Report ID: 1110 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 185
Interactive Wound Dressing Market Size, Share & Trends Analysis Report by Product (Semi-Permeable Films Dressing, Semi-Permeable Foam Dressing, And Hydrogel Dressing), Application (Chronic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers), End-Use (Hospitals, Outpatient Facilities, Home Care, And Research & Manufacturing), Region And Segment Forecasts, 2025-2034
Interactive Wound Dressing Market Size is valued at 4.59 billion in 2024 and is predicted to reach 7.32 billion by the year 2034 at a 4.9% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The market is propelled by a determination to transform the traditional method of wound care while simultaneously enhancing patient outcomes and decreasing complications. New wound dressing t...
Report ID: 1831 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Commercial Aquaculture Vaccines Market Size, Share & Trends Analysis Report By Pathogen Types (Bacteria and Viruses), Fish Species (Salmon, Tilapia, Bream, Labris Bergylta, Cyprinus Carpio, Sea Bass, Trout, and Cyclopterus Lumpur), End-Users, Region, And Segment Forecasts, 2023-2031
Commercial Aquaculture Vaccines Market Size is valued at 470.8 Million in 2024 and is predicted to reach 968.1 Million by the year 2034 at a 7.3 % CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The increasing consumption of seafood and the rising need for efficient disease management in intensive aquaculture systems boost the demand for vaccines Innovations in vaccine technology, includ...
Report ID: 1027 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 190
Oral Insulin Therapies Market Size, Share & Trends Analysis Report By Drug Class (Intermediate-Acting, Fast-Acting, and Long-Acting), By Application (Type 1 and Type 2 Diabetes), By Gender, Region And Segment Forecasts, 2025-2034.
Oral Insulin Therapies Market is expected to grow at a 35.5% CAGR during the forecast period for 2025-2034. In people with type 1 diabetes, the pancreas does not make insulin — a hormone that helps glucose get into your cells to give them energy — which is why they take insulin. In Type 2 diabetes people, the body does not make or use insulin well, and so insulin therapy may be needed. Daily insulin shots for the management of diab...
Report ID: 1102 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Oncology Drug Discovery & Development Market Size, Share & Trends Analysis Report By Drug/Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Others), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Leukemia Cancer, Lymphoma Cancer, Ovarian Cancer, Others), By Stage, By Region, And By Segment Forecasts, 2025-2034
Oncology Drug Discovery & Development Market Size is predicted to witness a 18.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The increase in global cancer prevalence is a major driver for the oncology drug discovery and development market. Advancements in cancer biology, genomics, and immunology are driving the oncology drug discovery and development market. Nort...
Report ID: 2211 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Continuous Manufacturing Equipment Providers Market Size, Share & Trends Analysis Report By Equipment (Mixers, Granulators, Dryers, Bioreactors / Reactors, and Other Equipment), Type of Molecule (Small Molecule and Biologics), Manufacturing Stage, Region, And Segment Forecasts, 2025-2034.
Continuous Manufacturing Equipment Providers Market is expected to grow at an 8.9% CAGR during the forecast period for 2025-2034. Continuous Manufacturing is a method that involves continuous manufacturing of equipment. This method makes the manufacturing process more fasters, efficient and beneficial. Continuous Manufacturing reduces interruptions in the production process, speeds up the process, and improves the yield. Less time investment, ...
Report ID: 1028 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
CD47 Targeting Therapeutics Market Size, Share & Trends Analysis Report By Target disease Indication (Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Colorectal Cancer, Diffuse Large B-cell Lymphoma, Other Diseases Indications), By Type of Molecule, By Region, And By Segment Forecasts, 2028-2034
CD47 Targeting Therapeutics Market is expected to grow at a 35% CAGR during the forecast period for 2028-2034. Key Industry Insights & Findings from the Report: The factors driving the growth of the CD47 targeting therapeutics market include the rising developments in the CD47-targeting anti-cancer therapies and growing demand for cost-efficient cancer treatments. Increasing government initiatives for canc...
Report ID: 1290 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Vascular Disrupting Agents Market Size, Share & Trends Analysis Report By Indication, By Therapeutic Area (Hematological Malignancies, Solid Tumors), By Product, By Molecule, By Therapy, By Route of Administration, By Region, And By Segment Forecasts, 2029-2034.
Vascular Disrupting Agents Market Size is predicted to grow at an 10% CAGR during the forecast period for 2029-2034. Vascular disrupting agents (VDAs) are a novel family of medications that target the existing tumour vasculature and cause tumour necrosis. As the world's population has aged, so has the global burden of cancer morbidity and mortality. Cancer is the primary or second leading cause of death among persons under the age of 70 ...
Report ID: 1299 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Hospital Energy Management Solutions Market Size, Share & Trends Analysis Report By Product (Equipment, Control System), By Application (Hospital Logistics Power, Hospital Emergency Logistics Power, Others), By Region, And By Segment Forecasts, 2025-2034
Hospital Energy Management Solutions Market Size predicted to reach represent a 8.5% CAGR during the forecast period for 2025-2034. Hospital Energy Management Systems (HEMS) optimize energy use in healthcare facilities, aiming to cut operational costs, boost patient comfort, and lessen environmental impact. These systems integrate advanced technology and strategies to manage energy consumption efficiently. Key elements include energy monitorin...
Report ID: 2349 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 179
Pharmaceuticals